Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine H Hughes

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|July 16, 2021
A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priorsJasmine H Hughes, Ron J Keizer
Molecular Biology of the Cell|October 20, 2017
Activation of ROCK and MLCK tunes regional stress fiber formation and mechanics via preferential myosin light chain phosphorylationElena Kassianidou, Jasmine H Hughes, Sanjay Kumar
Clinical Pharmacology and Therapeutics|May 1, 2026
The Visual Predictive Check and Real-World DataJasmine H Hughes, Martin Bergstrand, Ron J Keizer
Clinical Pharmacokinetics|February 8, 2026
Evaluation and Improvement of Specialized Vancomycin Pharmacokinetic Models for Pediatric Cardiovascular Intensive Care Unit and Pediatric Oncology PatientsMichael G McCarthy, Ron J Keizer, Jasmine H Hughes
Journal of Pharmacokinetics and Pharmacodynamics|March 23, 2024
Maximum a posteriori Bayesian methods out-perform non-compartmental analysis for busulfan precision dosingJasmine H Hughes, Janel Long-Boyle, Ron J Keizer
Pharmaceutics|October 27, 2022
Evaluating and Improving Neonatal Gentamicin Pharmacokinetic Models Using Aggregated Routine Clinical Care DataDominic M H Tong, Jasmine H Hughes, Ron J Keizer
Therapeutic Drug Monitoring|January 9, 2026
Improved Prediction of Vancomycin Pharmacokinetics in Patients Receiving Continuous Renal Replacement Therapy Using a Novel Population Model Validated With Real-World DataDominic M H Tong, Ron J Keizer, Jasmine H Hughes
Clinical Pharmacology and Therapeutics|November 21, 2022
Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health CareJasmine H Hughes, Kara H Woo, Ron J Keizer, et al.
Pharmacotherapy|October 9, 2024
Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi-site retrospective studyMaria-Stephanie A Hughes, Tiffany Lee, Jonathan D Faldasz, et al.
Jac-Antimicrobial Resistance|February 19, 2026
Vancomycin target attainment improved following population pharmacokinetic model switch: a large-scale quasi-experimental study of precision dosingDominic M H Tong, Jordan T Brooks, Ron J Keizer, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
CPT: Pharmacometrics & Systems Pharmacology|July 16, 2021
A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priorsJasmine H Hughes, Ron J Keizer
Molecular Biology of the Cell|October 20, 2017
Activation of ROCK and MLCK tunes regional stress fiber formation and mechanics via preferential myosin light chain phosphorylationElena Kassianidou, Jasmine H Hughes, Sanjay Kumar
Clinical Pharmacology and Therapeutics|May 1, 2026
The Visual Predictive Check and Real-World DataJasmine H Hughes, Martin Bergstrand, Ron J Keizer
Clinical Pharmacokinetics|February 8, 2026
Evaluation and Improvement of Specialized Vancomycin Pharmacokinetic Models for Pediatric Cardiovascular Intensive Care Unit and Pediatric Oncology PatientsMichael G McCarthy, Ron J Keizer, Jasmine H Hughes
Journal of Pharmacokinetics and Pharmacodynamics|March 23, 2024
Maximum a posteriori Bayesian methods out-perform non-compartmental analysis for busulfan precision dosingJasmine H Hughes, Janel Long-Boyle, Ron J Keizer
Pharmaceutics|October 27, 2022
Evaluating and Improving Neonatal Gentamicin Pharmacokinetic Models Using Aggregated Routine Clinical Care DataDominic M H Tong, Jasmine H Hughes, Ron J Keizer
Therapeutic Drug Monitoring|January 9, 2026
Improved Prediction of Vancomycin Pharmacokinetics in Patients Receiving Continuous Renal Replacement Therapy Using a Novel Population Model Validated With Real-World DataDominic M H Tong, Ron J Keizer, Jasmine H Hughes
Clinical Pharmacology and Therapeutics|November 21, 2022
Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health CareJasmine H Hughes, Kara H Woo, Ron J Keizer, et al.
Pharmacotherapy|October 9, 2024
Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi-site retrospective studyMaria-Stephanie A Hughes, Tiffany Lee, Jonathan D Faldasz, et al.
Jac-Antimicrobial Resistance|February 19, 2026
Vancomycin target attainment improved following population pharmacokinetic model switch: a large-scale quasi-experimental study of precision dosingDominic M H Tong, Jordan T Brooks, Ron J Keizer, et al.
Pageof 2